| . "Spatial regression with covariate measurement error: A semiparametric approach.." Biometrics. 2016;72(3):678-86. Pub Med |
| . "Duration of eptifibatide infusion after percutaneous coronary intervention and outcomes among high-risk patients with non-ST-segment elevation acute coronary syndrome: insights from EARLY ACS.." Eur Heart J Acute Cardiovasc Care. 2013;2(3):246-55. Pub Med |
| . "Translational studies of phenotypic probes for the mononuclear phagocyte system and liposomal pharmacology.." J Pharmacol Exp Ther. 2013;347(3):599-606. Pub Med |
| . "Generation of a transcriptional radiation exposure signature in human blood using long-read nanopore sequencing.." Radiat Res. 2020;193(2):143-154. Pub Med |
| . "Provider-based research networks and diffusion of surgical technologies among patients with early-stage kidney cancer.." Cancer. 2015;121(6):836-43. Pub Med |
| . "Meta-analysis of sequencing studies with heterogeneous genetic associations.." Genet Epidemiol. 2014;38(5):389-401. Pub Med |
| . "Development and validation of a natural language processing tool to generate the CONSORT reporting checklist for randomized clinical trials.." JAMA Netw Open. 2020;3(10):e2014661. Pub Med |
| . "A framework for understanding cancer comparative effectiveness research data needs.." J Clin Epidemiol. 2012;65(11):1150-8. Pub Med |
| . "Celecoxib with neoadjuvant chemotherapy for breast cancer might worsen outcomes differentially by COX-2 expression and ER status: Exploratory analysis of the REMAGUS02 trial.." J Clin Oncol. 2019;37(8):624-635. Pub Med |
| . "A comparison of proposed biosimilar LA-EP2006 and reference Pegfilgrastim for the prevention of neutropenia in patients with early-stage breast cancer receiving Myelosuppressive adjuvant or Neoadjuvant chemotherapy: Pegfilgrastim Randomized Oncology (Supp." Oncologist. 2016;21(7):789-94. Pub Med |
| . "Onset of persistent pseudomonas aeruginosa infection in children with cystic fibrosis with interval censored data.." BMC Med Res Methodol. 2016;16(1):122. Pub Med |
| . "Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR(+), HER2(-) breast cancer that had progressed during or after prior endocrine therapy.." Breast Cancer Res. 2017;19(1):18. Pub Med |
| . "Systematic review and network meta-analysis comparing palbociclib with chemotherapy agents for the treatment of postmenopausal women with HR-positive and HER2-negative advanced/metastatic breast cancer.." Breast Cancer Res Treat. 2017;166(1):167-177. Pub Med |
| . "Celecoxib with neoadjuvant chemotherapy for breast cancer might worsen outcomes differentially by COX-2 expression and ER status: Exploratory analysis of the REMAGUS02 trial.." J Clin Oncol. 2019;37(8):624-635. Pub Med |
| . "Clinical prognostic model for older patients with advanced non-small cell lung cancer.." J Geriatr Oncol. 2019;10(4):555-559. Pub Med |
| . "The long noncoding RNA promotes sarcoma metastasis by regulating RNA splicing pathways.." Mol Cancer Res. 2020;18(10):1534-1544. Pub Med |
| . "Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells.." J Biol Chem. 2019;294(15):5914-5922. Pub Med |
| . "Accelerated intensity frailty model for recurrent events data.." Biometrics. 2014;70(3):579-87. Pub Med |
| . "Bayesian methods in clinical trials: A Bayesian analysis of ECOG trials E1684 and E1690.." BMC Med Res Methodol. 2012;12():183. Pub Med |
| . "Network meta-analysis of margin threshold for women with ductal carcinoma in situ.." J Natl Cancer Inst. 2012;104(7):507-16. Pub Med |
| . "A simple and robust method for multivariate meta-analysis of diagnostic test accuracy.." Stat Med. 2017;36(1):105-121. Pub Med |
| . "Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR(+), HER2(-) breast cancer that had progressed during or after prior endocrine therapy.." Breast Cancer Res. 2017;19(1):18. Pub Med |
| . "Systematic review and network meta-analysis comparing palbociclib with chemotherapy agents for the treatment of postmenopausal women with HR-positive and HER2-negative advanced/metastatic breast cancer.." Breast Cancer Res Treat. 2017;166(1):167-177. Pub Med |
| . "Provider-based research networks and diffusion of surgical technologies among patients with early-stage kidney cancer.." Cancer. 2015;121(6):836-43. Pub Med |
| . "Pooled analysis of individual patient data on concurrent chemoradiotherapy for stage III non-small-cell lung cancer in elderly patients compared with younger patients who participated in US National Cancer Institute Cooperative Group Studies.." J Clin Oncol. 2017;35(25):2885-2892. Pub Med |
| . "Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.." J Natl Cancer Inst. 2012;104(3):211-27. Pub Med |
| . "Validation of survival prognostic models for non-small-cell lung cancer in stage- and age-specific groups.." Lung Cancer. 2015;90(2):281-7. Pub Med |
| . "A comparison of proposed biosimilar LA-EP2006 and reference Pegfilgrastim for the prevention of neutropenia in patients with early-stage breast cancer receiving Myelosuppressive adjuvant or Neoadjuvant chemotherapy: Pegfilgrastim Randomized Oncology (Supp." Oncologist. 2016;21(7):789-94. Pub Med |
| . "PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation.." Sci Transl Med. 2016;8(369):369ra175. Pub Med |
| . "DiNAMIC: A method to identify recurrent DNA copy number aberrations in tumors.." Bioinformatics. 2011;27(5):678-85. Pub Med |
| . "Global copy number profiling of cancer genomes.." Bioinformatics. 2016;32(6):926-8. Pub Med |
| . "Integrative pipeline for profiling DNA copy number and inferring tumor phylogeny.." Bioinformatics. 2018;34(12):2126-2128. Pub Med |
| . "Assessing the dependence of sensitivity and specificity on prevalence in meta-analysis.." Biostatistics. 2011;12(4):710-22. Pub Med |
| . "Prediction of cancer drug sensitivity using high-dimensional omic features.." Biostatistics. 2017;18(1):1-14. Pub Med |
| . "permGPU: Using graphics processing units in RNA microarray association studies.." BMC Bioinformatics. 2010;11():329. Pub Med |
| . "Incorporating higher-order representative features improves prediction in network-based cancer prognosis analysis.." BMC Med Genomics. 2011;4():5. Pub Med |
| . "Data for cancer comparative effectiveness research: past, present, and future potential.." Cancer. 2012;118(21):5186-97. Pub Med |
| . "SCOPE: A normalization and copy-number estimation method for single-cell DNA sequencing.." Cell Syst. 2020;10(5):445-452.e6. Pub Med |
| . "Statistical aspect of translational and correlative studies in clinical trials.." Chin Clin Oncol. 2016;5(1):11. Pub Med |
| . "CRM2DIM: A SAS macro for implementing the dual-agent Bayesian continual reassessment method.." Comput Methods Programs Biomed. 2019;176():211-223. Pub Med |
| . "Statistical issues for design and analysis of single-arm multi-stage phase II cancer clinical trials.." Contemp Clin Trials. 2015;42():9-17. Pub Med |
| . "Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome.." Eur Heart J. 2016;37(4):412-22. Pub Med |
| . "I-Boost: An integrative boosting approach for predicting survival time with multiple genomics platforms.." Genome Biol. 2019;20(1):52. Pub Med |
| . "SynthEx: a synthetic-normal-based DNA sequencing tool for copy number alteration detection and tumor heterogeneity profiling.." Genome Biol. 2017;18(1):66. Pub Med |
| . "Associating somatic mutations to clinical outcomes: a pan-cancer study of survival time.." Genome Med. 2019;11(1):37. Pub Med |
| . "Statistical issues and advances in cancer precision medicine research.." J Biopharm Stat. 2018;28(2):215-216. Pub Med |
| . "Phase II cancer clinical trials with heterogeneous patient populations.." J Biopharm Stat. 2012;22(2):312-28. Pub Med |
| . "Phase II cancer clinical trials for biomarker-guided treatments.." J Biopharm Stat. 2018;28(2):256-263. Pub Med |
| . "On sample size calculation for comparing survival curves under general hypothesis testing.." J Biopharm Stat. 2012;22(3):485-95. Pub Med |
| . "The use of Bayesian hierarchical models for adaptive randomization in biomarker-driven phase II studies.." J Biopharm Stat. 2015;25(1):66-88. Pub Med |
